Evidence map›Paper›PMID 36963390›Full record

ArticleStem cell reports2023

Generation of functional thymic organoids from human pluripotent stem cells.

Stephan A Ramos, Lucas H Armitage, John J Morton, Nathaniel Alzofon, Diana Handler, Geoffrey Kelly, Dirk Homann, Antonio Jimeno, Holger A Russ

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Article
  12. Informed clinical decisions by outfoxing human FOXN1 variants.The Journal of allergy and clinical immunology · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Stephan A RamosBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Lucas H ArmitageBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
John J MortonDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Nathaniel AlzofonDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Diana HandlerHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Geoffrey KellyHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Dirk HomannDiabetes, Metabolism and Obesity Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Antonio JimenoDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA; Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Holger A RussBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA; Diabetes Institute, University of Florida, Gainesville, FL 32610, USA; Department of Pathology and Therapeutics, University of Florida, Gainesville, FL 32610, USA. Electronic address: holger.russ@ufl.edu.
Icahn School of Medicine at Mount Sinai · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN).U24DK104162 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI John S. Kaddis, Joyce Carol Niland · 2019 to 2026
$12.3M
University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Human Pancreas Analysis Program-T2DU01DK123716 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ATKINSON, MARK A., BOTTINO, RITA · 2019 to 2024
$6.6M
Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancerR01CA149456 · NCI · UNIVERSITY OF COLORADO DENVER · PI Antonio Jimeno · 2010 to 2026
$5.6M
Development of an autologous humanized model of melanoma exploring human thymic education capacityR01CA213102 · NCI · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO · 2017 to 2019
$1.7M
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.R01DK120444 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI RUSS, HOLGER A. · 2018 to 2021
$1.5M
Experimental and natural SARS-CoV-2 infection of the human pancreasR01DK130425 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOMANN, DIRK, SCHOTSAERT, MICHAEL · 2021 to 2023
$1.3M
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA149456NCI NIH HHS R01 CA213102NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK116073NIDDK NIH HHS R01 DK120444NIDDK NIH HHS R01 DK130425NIDDK NIH HHS U01 DK123716NIDDK NIH HHS U24 DK104162
6 · The paper itself

Abstract

The thymus is critical for the establishment of a functional and self-tolerant adaptive immune system but involutes with age, resulting in reduced naive T cell output. Generation of a functional human thymus from human pluripotent stem cells (hPSCs) is an attractive regenerative strategy. Direct differentiation of thymic epithelial progenitors (TEPs) from hPSCs has been demonstrated in vitro, but functional thymic epithelial cells (TECs) only form months after transplantation of TEPs in vivo. We show the generation of TECs in vitro in isogenic stem cell-derived thymic organoids (sTOs) consisting of TEPs, hematopoietic progenitor cells, and mesenchymal cells, differentiated from the same hPSC line. sTOs support T cell development, express key markers of negative selection, including the autoimmune regulator (AIRE) protein, and facilitate regulatory T cell development. sTOs provide the basis for functional patient-specific thymic organoid models, allowing for the study of human thymus function, T cell development, and transplant immunity.

Indexed as

Pluripotent Stem CellsThymus GlandCell DifferentiationEpithelial CellsHumansOrganoidsT-Lymphocytescell therapyhuman pluripotent stem cellshuman T cell developmentpositive and negative selectionstem cell derived thymic organoidsthymic epithelial cells

Identifiers

PMID36963390
PMCPMC10147832
OpenAlexW4360610905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.